August 15, 2012 — Sound Interventions Inc. has released three-month data from the company's first-in-human clinical ...
Hypertension
This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics and renal denervation therapy.
June 1, 2012 — Kona Medical Inc. announced it has raised $30 million in Series C financing to advance its novel ...
May 18, 2012 -- St. Jude Medical Inc., a global medical device company, announced that preliminary data demonstrated the ...
May 15, 2012 – St. Jude Medical Inc. announced CE mark approval and launch of its EnligHTN renal denervation system ...
May 9, 2012 — Sound Interventions Inc. announced the successful completion of the company's first-in-human renal ...
May 4, 2012 - Medtronic Inc. announced six-month pooled outcomes from randomized and crossover patients in the ...
May 2, 2012 — Vessix Vascular Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology ...
April 11, 2012 — ReCor Medical disclosed updated data for the REDUCE First-In-Man clinical study of its CE-marked ...
April 4, 2012 — Medtronic Inc. announced that the Symplicity renal denervation system provides safe, significant and ...
March 29, 2012 — Internet-based telemedicine systems appear to lead to more appropriate and effective pharmacotherapy ...
February 29, 2012 — Vessix Vascular Inc. announced initial patient treatments in the international multicenter Reduce ...
February 20, 2012 — ReCor Medical announced that its Paradise percutaneous ultrasound renal denervation system for ...
February 15, 2012 — Vessix Vascular Inc., developer of a novel percutaneous radiofrequency (RF) balloon catheter ...
February 15, 2012 — Medtronic Inc. announced the start of two clinical initiatives evaluating the broader, real-world ...
October 26, 2011 — Medtronic Inc. announced the start of SYMPLICITY HTN-3, the company’s United States clinical trial of ...